Ossiam’s Agilon Health AGL Stock Holding History

Ossiam’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-163	Closed	-$51.2K	–	627
2023 Q4	$51.2K	Hold	163	–	–	﹤0.01%	642
2023 Q3	$72.5K	Sell	163 -27	-14%	-$12.2K	﹤0.01%	646
2023 Q2	$82.3K	Buy	190 +77	+68%	+$43.3K	﹤0.01%	690
2023 Q1	$67.2K	Buy	113 +34	+43%	+$19K	﹤0.01%	659
2022 Q4	$31.9K	Hold	79	–	–	﹤0.01%	693
2022 Q3	$46K	Buy	+79	New	+$47.3K	﹤0.01%	681

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ossiam's AGL Position: Q1 2024 in Review

Ossiam sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 163 shares — an estimated $51.2K sold.

Ossiam first reported a position in AGL in Q3 2022 and held it in 6 quarters. The position peaked at $82.3K in Q2 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

Ossiam reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
Ossiam sold 163 Agilon Health shares in Q1 2024, an estimated $51.2K.
Ossiam first reported a position in Agilon Health in Q3 2022 and held it in 6 quarters.
Ossiam's Agilon Health position peaked at $82.3K in Q2 2023.
198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Ossiam's 13F filing for Q1 2024, filed 13 May 2024.